SCHEMBL20007407

SCHEMBL20007407

COc1ccc(C(=O)/C=C\Nc2cc(/C=C\c3cc(O)c(OC)c(OC)c3)cc(OC)c2OC)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 4/20 0.62
▸ POLB P06746 1/20 0.56
▸ GAA P10253 1/20 0.56
▸ CXCL12 P48061 1/20 0.54
▸ MEN1 O00255 5/20 0.53
▸ KMT2A Q03164 5/20 0.53
▸ RAB9A P51151 2/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ PKM P14618 1/20 0.52
▸ KLF5 Q13887 1/20 0.52
▸ MAPT P10636 4/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ LMNA P02545 2/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ ABCG2 Q9UNQ0 1/20 0.51
▸ MCL1 Q07820 1/20 0.51
▸ CA1 P00915 3/20 0.50
▸ CA2 P00918 3/20 0.50
▸ TNFRSF1A P19438 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17237026 0.96 KRAS (0.65) KRASPOLBGAACXCL12MEN1
SCHEMBL17237029 0.96 KRAS (0.65) KRASPOLBGAACXCL12MEN1
SCHEMBL17237164 0.93 KRAS (0.71) KRASPOLBGAAMEN1KMT2A
SCHEMBL17237168 0.93 KRAS (0.71) KRASPOLBGAAMEN1KMT2A
SCHEMBL20007046 0.88 POLB (0.67) KRASPOLBGAACXCL12MEN1
SCHEMBL17237423 0.88 ABCG2 (0.55) KRASMEN1KMT2AMAPTALDH1A1
SCHEMBL17237422 0.88 ABCG2 (0.55) KRASMEN1KMT2AMAPTALDH1A1
SCHEMBL17251600 0.87 CA1 (0.65) KRASGAACXCL12MEN1KMT2A
SCHEMBL17236730 0.87 KRAS (0.57) KRASPOLBGAAMEN1KMT2A
SCHEMBL17236731 0.87 KRAS (0.57) KRASPOLBGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2942345-B1 3,4,5-TRIMETHOXYSTYRYLARYLAMINOPROPENONES FOR THE TREATMENT OF CANCER COUNCIL SCIENT IND RES (IN) 2018-03-28 — — EP disclosed
Send feedback